Worrall N K, Misko T P, Botney M D, Sullivan P M, Hui J J, Suau G M, Manning P T, Ferguson T B
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Ann Thorac Surg. 1999 Mar;67(3):716-22. doi: 10.1016/s0003-4975(98)01346-0.
We have demonstrated that inhibition of inducible nitric oxide synthase (NOS) ameliorated acute cardiac allograft rejection. This study determined the time course and cellular localization of inducible NOS expression during the histologic progression of unmodified acute rat cardiac allograft rejection.
Tissue from syngeneic (ACI to ACI) and allogeneic (Lewis to ACI) transplants were harvested on postoperative days 3 through 10 and analyzed for inducible NOS mRNA expression (ribonuclease protection assay), inducible NOS enzyme activity (conversion of L-[3H]arginine to nitric oxide and L-[3H]citrulline), and nitric oxide production (serum nitrite/nitrate levels). Inducible NOS mRNA and protein expression were localized using in situ hybridization and immunohistochemistry.
Inducible NOS mRNA and enzyme activity were expressed in allografts during mild, moderate, and severe acute rejection (postoperative days 4 through 10), but were not detected in normals, isografts, or allografts before histologic changes of mild acute rejection (postoperative day 3). Inducible NOS expression resulted in increased serum nitrite/nitrate levels during mild and moderate rejection (postoperative days 4 through 6). Inducible NOS mRNA and protein expression localized to infiltrating mononuclear inflammatory cells in allograft tissue sections during all stages of rejection but were not detected in allograft parenchymal cells or in normals or isografts.
Inducible NOS expression and increased nitric oxide production occurred during the early stages of acute rejection, persisted throughout the unmodified rejection process, and localized to infiltrating inflammatory cells but not allograft parenchymal cells during all stages of acute rejection.
我们已经证明,抑制诱导型一氧化氮合酶(NOS)可改善急性心脏移植排斥反应。本研究确定了在未修饰的急性大鼠心脏移植排斥反应的组织学进展过程中,诱导型NOS表达的时间进程和细胞定位。
在术后第3至10天采集同基因(ACI至ACI)和异基因(Lewis至ACI)移植组织,分析诱导型NOS mRNA表达(核糖核酸酶保护分析)、诱导型NOS酶活性(L-[3H]精氨酸转化为一氧化氮和L-[3H]瓜氨酸)以及一氧化氮生成(血清亚硝酸盐/硝酸盐水平)。使用原位杂交和免疫组织化学对诱导型NOS mRNA和蛋白表达进行定位。
在轻度、中度和重度急性排斥反应期间(术后第4至10天),异基因移植组织中均有诱导型NOS mRNA和酶活性表达,但在正常组织、同基因移植组织或轻度急性排斥反应组织学改变之前(术后第3天)的异基因移植组织中未检测到。在轻度和中度排斥反应期间(术后第4至6天),诱导型NOS表达导致血清亚硝酸盐/硝酸盐水平升高。在排斥反应的所有阶段,诱导型NOS mRNA和蛋白表达定位于异基因移植组织切片中的浸润性单核炎性细胞,但在异基因移植实质细胞、正常组织或同基因移植组织中未检测到。
诱导型NOS表达和一氧化氮生成增加发生在急性排斥反应的早期阶段,在整个未修饰的排斥反应过程中持续存在,并且在急性排斥反应的所有阶段定位于浸润性炎性细胞而非异基因移植实质细胞。